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uthor’s reply
ear Dr Cheng,
Thank you for your comments on our work. As
ou mentioned, it is sometimes difﬁcult to dis-
inguish hypertrophic cardiomyopathy (HCM) from
thlete’s heart. Delayed gadolinium enhancement
DGE) in cardiac magnetic resonance (CMR) and
lasma brain natriuretic peptide (BNP) levels may
e useful to detect high risk HCM patients in
oung athletes. However, changes in these param-
ters may be smaller in young HCM patients than
n our study population (mean age 67.4 years).
oreover, cardiac hypertrophy progresses rapidly
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plasma BNP levels for diagnosing HCM in young ath-
letes.
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∗ Tel.: +81 798 45 6553; fax: +81 798 45 6551.n young people, especially in adolescence [1]. A
ingle examination of CMR and/or BNP may not
e sensitive enough to exclude high risk HCM in
oung people. Further studies are necessary to
stablish the usefulness of DGE in CMR and/or d
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